FDA approves Cosette Pharmaceuticals' EVOXAC
– – New Oral Solution Formulation Developed for Patients Living with Sjögren’s Disease demonstrates Cosette's expanding capabilities in product development and innovation – –– – Product Expected to be Commercially
Share
Why It Matters
Cosette Pharmaceuticals got permission to sell a new medicine for Sjögren's disease. This shows the company can develop new products, which could help it grow.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.